Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Atrasentan Spermatogenesis and Testicular Function

ClinicalTrials.gov ID: NCT02118714

Public ClinicalTrials.gov record NCT02118714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the effects of Atrasentan on sperm production and testicular function in male subjects with Type 1 or 2 Diabetes and Nephropathy. This study included 2 periods: a Treatment Period (up to 26 weeks) followed by an Observational Period (up to an additional 52 weeks).

Study identification

NCT ID
NCT02118714
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2015 (Actual)
Primary completion
Apr 18, 2018 (Actual)
Completion
Jul 16, 2018 (Actual)
Last update posted
May 7, 2019

2015 – 2018

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Alliance Research Centers /ID# 125945 Laguna Hills California 92653-3621 —
Frank Clark Urology Center /ID# 147794 Santa Monica California 90404 —
Research by Design, LLC /ID# 160784 Evergreen Park Illinois 60805 —
Southern IL Univ School of Med /ID# 129010 Springfield Illinois 62702 —
Crescent City Clinical Res Ctr /ID# 150989 Metairie Louisiana 70006 —
Tulane Univ /ID# 130308 New Orleans Louisiana 70112 —
Albany Medical College /ID# 131068 Albany New York 12208 —
Urologic Consultants of Southeastern Pennsylvania /ID# 124277 Bala-Cynwyd Pennsylvania 19004-1017 —
Eastern Virginia Med School /ID# 153740 Norfolk Virginia 23507-1627 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02118714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02118714 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →